Deborah Dunsire

President & Chief Executive Officer at H. Lundbeck A/S

Deborah Dunsire

Deborah Dunsire

President & Chief Executive Officer at H. Lundbeck A/S

Overview
Career Highlights

H. Lundbeck A/S
XTuit Pharmaceuticals, Inc.
Takeda Oncology Co.

RelSci Relationships

2153

Number of Boards

15

Birthday

1962

Age

57

Contact Data
Trying to get in touch with Deborah Dunsire? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Deborah Dunsire likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director-Tumor Biology Steele Lab at The Massachusetts General Hospital

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Coda Biotherapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Pandion Therapeutics, Inc.

Relationship likelihood: Strong

President at International Council of Ophthalmology Foundation

Relationship likelihood: Strong

Executive Vice President & Head of Research Development at H. Lundbeck A/S

Relationship likelihood: Strong

Former Product Management at General Foods Corp.

Relationship likelihood: Strong

Founder at New England Healthcare Institute

Relationship likelihood: Strong

General Partner, Washington DC at New Enterprise Associates

Relationship likelihood: Strong

Former Executive Chairman at Relay Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Deborah Dunsire
Potential Connections via
Relationship Science
You
Deborah Dunsire
President & Chief Executive Officer at H. Lundbeck A/S
Education
Doctorate Degree

The University of the Witwatersrand, Johannesburg, is a multi-campus South African public research university situated in the northern areas of central Johannesburg. It is more commonly known as Wits University. The university has its roots in the mining industry, as do Johannesburg and the Witwatersrand in general. Founded in 1896 as the South African School of Mines in Kimberley, it is the third oldest South African university in continuous operation, after the University of Cape Town and Stellenbosch University.

Career History
President & Chief Executive Officer
2018 - Current

H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

President, Chief Executive Officer & Director
2017 - 2018

XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical Products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA.

President & Chief Executive Officer
2005 - 2013

Takeda Oncology Co. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Boards & Committees
Member, Management Committee
2005 - 2013

Takeda Oncology Co. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Director
2005 - 2008

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country's biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Director
2002 - 2005

CHI was founded in 1993 as an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California’s biomedical community.

Member, Board of Trustees
Prior

Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 - $10K
2014

Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Attendee
Tianjin, GD, China
2012 World Economic Forum Annual Meeting of the New Champions

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Deborah Dunsire. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Deborah Dunsire's profile does not indicate a business or promotional relationship of any kind between RelSci and Deborah Dunsire.